TRPM2, TFEB and LAL: A New Link

TRPM2, TFEB and LAL: A New Link

New Research Identifies a Pathway Regulating Lysosomal Acid Lipase (LAL) Activity and Lysosomal Health Research into lysosomal diseases continues to advance, providing new insights into the cellular mechanisms that maintain metabolic balance. A recent study published...
University of Rochester – Phase 4 Study

University of Rochester – Phase 4 Study

University of Rochester Seeks Participants for Final Validation Study of a New Lysosomal Acid Lipase Deficiency (LAL-D) Assessment Tool The University of Rochester (United States) is conducting the final phase of a research study aimed at developing and validating the...
The FC Barcelona Foundation supporting Rare Diseases

The FC Barcelona Foundation supporting Rare Diseases

Martina, affected by LAL-D, represented the LAL-D Patient Organization at the event On the occasion of World Rare Disease Day, the FC Barcelona Foundation made it possible for girls affected by rare diseases to experience a truly unforgettable day alongside the...
Rare Disease Day

Rare Disease Day

RARE DISEASE DAY 2026 February 28th marks Rare Disease Day. Early diagnosis can change a life. High cholesterol is very common in the population. However, in some cases it may be a sign of a rare condition such as lysosomal acid lipase deficiency (LAL‑D). If you have:...
Grupo Copese collaborates with El Viaje de Nica

Grupo Copese collaborates with El Viaje de Nica

Grupo Alimentario Copese We are incredibly happy to share this news. 💜 Thanks to the outreach efforts of the people involved in our association, Grupo Copese learned about the El Viaje de Nica campaign, led by FEDER and Sant Joan de Déu Hospital, with the support of...